These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1925 related items for PubMed ID: 16686707

  • 1. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
    Weckermann D, Goppelt M, Dorn R, Wawroschek F, Harzmann R.
    BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
    [Abstract] [Full Text] [Related]

  • 2. Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients.
    Weckermann D, Dorn R, Trefz M, Wagner T, Wawroschek F, Harzmann R.
    J Urol; 2007 Mar; 177(3):916-20. PubMed ID: 17296375
    [Abstract] [Full Text] [Related]

  • 3. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.
    DiMarco DS, Zincke H, Sebo TJ, Slezak J, Bergstralh EJ, Blute ML.
    J Urol; 2005 Apr; 173(4):1121-5. PubMed ID: 15758719
    [Abstract] [Full Text] [Related]

  • 4. Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy.
    Arenas LF, Füllhase C, Boemans P, Fichtner J.
    Aktuelle Urol; 2010 Jan; 41 Suppl 1():S10-4. PubMed ID: 20094944
    [Abstract] [Full Text] [Related]

  • 5. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy.
    Kroepfl D, Loewen H, Roggenbuck U, Musch M, Klevecka V.
    BJU Int; 2006 May; 97(5):985-91. PubMed ID: 16643480
    [Abstract] [Full Text] [Related]

  • 6. Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer.
    Kupelian P, Katcher J, Levin H, Zippe C, Klein E.
    Urology; 1996 Aug; 48(2):249-60. PubMed ID: 8753737
    [Abstract] [Full Text] [Related]

  • 7. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
    Heidenreich A, Varga Z, Von Knobloch R.
    J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
    [Abstract] [Full Text] [Related]

  • 8. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.
    Boorjian SA, Thompson RH, Siddiqui S, Bagniewski S, Bergstralh EJ, Karnes RJ, Frank I, Blute ML.
    J Urol; 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342
    [Abstract] [Full Text] [Related]

  • 9. Is there a need for pelvic lymph node dissection in low risk prostate cancer patients prior to definitive local therapy?
    Weckermann D, Wawroschek F, Harzmann R.
    Eur Urol; 2005 Jan; 47(1):45-50; discussion 50-1. PubMed ID: 15582248
    [Abstract] [Full Text] [Related]

  • 10. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.
    Cagiannos I, Karakiewicz P, Eastham JA, Ohori M, Rabbani F, Gerigk C, Reuter V, Graefen M, Hammerer PG, Erbersdobler A, Huland H, Kupelian P, Klein E, Quinn DI, Henshall SM, Grygiel JJ, Sutherland RL, Stricker PD, Morash CG, Scardino PT, Kattan MW.
    J Urol; 2003 Nov; 170(5):1798-803. PubMed ID: 14532779
    [Abstract] [Full Text] [Related]

  • 11. [The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer].
    Heidenreich A, Ohlmann CH.
    Aktuelle Urol; 2005 Jun; 36(3):219-29. PubMed ID: 16001337
    [Abstract] [Full Text] [Related]

  • 12. [Complete radical prostatectomy and positive lymph nodes (stages pT1 to 4, N1 to 3, M0, D1)].
    Feyaerts A, Stainier L, Nollevaux MC, De Groote P, Lorge F, Opsomer R, Wese FX, Cosyns JP, Van Cangh P.
    Acta Urol Belg; 1998 Mar; 66(1):1-6. PubMed ID: 9611351
    [Abstract] [Full Text] [Related]

  • 13. Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.
    Steuber T, Budäus L, Walz J, Zorn KC, Schlomm T, Chun F, Ahyai S, Fisch M, Sauter G, Huland H, Graefen M, Haese A.
    BJU Int; 2011 Jun; 107(11):1755-61. PubMed ID: 20942833
    [Abstract] [Full Text] [Related]

  • 14. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF, Cozzarini C, Briganti A, Suardi N, Salonia A, Bertini R, Gallina A, Bianchi M, Fantini GV, Bolognesi A, Fazio F, Montorsi F, Rigatti P.
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [Abstract] [Full Text] [Related]

  • 15. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?
    Bader P, Burkhard FC, Markwalder R, Studer UE.
    J Urol; 2003 Mar; 169(3):849-54. PubMed ID: 12576797
    [Abstract] [Full Text] [Related]

  • 16. Radical prostatectomy for clinical stage T3a disease.
    Freedland SJ, Partin AW, Humphreys EB, Mangold LA, Walsh PC.
    Cancer; 2007 Apr 01; 109(7):1273-8. PubMed ID: 17315165
    [Abstract] [Full Text] [Related]

  • 17. Contemporary survival results and the role of radiation therapy in patients with node negative seminal vesicle invasion following radical prostatectomy.
    Eggener SE, Roehl KA, Smith ND, Antenor JA, Han M, Catalona WJ.
    J Urol; 2005 Apr 01; 173(4):1150-5. PubMed ID: 15758725
    [Abstract] [Full Text] [Related]

  • 18. Is pelvic lymph node dissection necessary in patients with a serum PSA<10ng/ml undergoing radical prostatectomy for prostate cancer?
    Schumacher MC, Burkhard FC, Thalmann GN, Fleischmann A, Studer UE.
    Eur Urol; 2006 Aug 01; 50(2):272-9. PubMed ID: 16632187
    [Abstract] [Full Text] [Related]

  • 19. No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer.
    Bhatta-Dhar N, Reuther AM, Zippe C, Klein EA.
    Urology; 2004 Mar 01; 63(3):528-31. PubMed ID: 15028451
    [Abstract] [Full Text] [Related]

  • 20. Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer.
    Briganti A, Chun FK, Salonia A, Gallina A, Farina E, Da Pozzo LF, Rigatti P, Montorsi F, Karakiewicz PI.
    BJU Int; 2006 Oct 01; 98(4):788-93. PubMed ID: 16796698
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 97.